You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 59 Issue 1

January 2005

Volume 59, Issue 1

Pages 1–139

  1. Editors’ View

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      Internationality (pages 1–4)

      J. K. Aronson and Elizabeth Whelan

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02352.x

  2. Pharmacodynamics

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
  3. Pharmacogenetics

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype (pages 14–17)

      Yifan Zhang, Dafang Zhong, Dayong Si, Yingjie Guo, Xiaoyan Chen and Hui Zhou

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02223.x

      • image
  4. Pharmacokinetics

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients (pages 18–27)

      Hélène Bourgoin, Gilles Paintaud, Matthias Büchler, Yvon Lebranchu, Elisabeth Autret-Leca, France Mentré and Chantal Le Guellec

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02200.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC® study (pages 28–37)

      Ziad Hussein, Maria Pitsiu, Oneeb Majid, Leon Aarons, Marc De Longueville, Armel Stockis and the ETAC® Study Group

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02242.x

      • image
      • image
      • image
      • image
    3. You have free access to this content
      Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects (pages 38–42)

      Marta Boffito, David Back, Meredith Stainsby-Tron, Andrew Hill, Giovanni Di Perri, Graeme Moyle, Mark Nelson, Jaqui Tomkins, Brian Gazzard and Anton Pozniak

      Version of Record online: 27 OCT 2004 | DOI: 10.1111/j.1365-2125.2004.02240.x

    4. You have free access to this content
      Population pharmacokinetics of epinastine, a histamine H1 receptor antagonist, in adults and children (pages 43–53)

      A. Sarashina, S. Tatami, N. Yamamura, Y. Tsuda and T. Igarashi

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.2250

      • image
      • image
      • image
      • image
      • image
      • image
    5. You have free access to this content
      The effect of sepsis upon gentamicin pharmacokinetics in neonates (pages 54–61)

      M. Lingvall, D. Reith and R. Broadbent

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02260.x

      • image
  5. Drug Metabolism

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects (pages 62–68)

      Carmen Martínez, Elena García-Martín, Gerardo Blanco, Francisco J. G. Gamito, José M. Ladero and José A. G. Agúndez

      Version of Record online: 27 JUL 2004 | DOI: 10.1111/j.1365-2125.2004.02183.x

      • image
    2. You have free access to this content
      Authors’ note (page 69)

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02353.x

    3. You have free access to this content
      The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects (pages 70–79)

      M. W. Hruska, J. A. Amico, T. Y. Langaee, R. E. Ferrell, S. M. Fitzgerald and R. F. Frye

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02263.x

      • image
      • image
      • image
      • image
  6. Drug Distribution

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      Bioavailability of diclofenac potassium at low doses (pages 80–84)

      Burkhard Hinz, Julia Chevts, Bertold Renner, Henrike Wuttke, Thomas Rau, Andreas Schmidt, Istvan Szelenyi, Kay Brune and Ulrike Werner

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02226.x

      • image
  7. Therapeutics

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
  8. Clinical Trials

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
  9. Short Reports

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin (pages 102–107)

      David N. Juurlink, Muhammad M. Mamdani, Alexander Kopp, Nathan Herrmann and Andreas Laupacis

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02230.x

    2. You have free access to this content
      National differences in publishing papers on adverse drug reactions (pages 108–111)

      R. E. Ferner and J. K. Aronson

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02267.x

      • image
      • image
    3. You have free access to this content
      National Prescribing Service: creating an implementation arm for national medicines policy (pages 112–116)

      L. M. Weekes, J. M. Mackson, M. Fitzgerald and S. R. Phillips

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.02231.x

  10. Book Review

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
  11. Letters to the Editor

    1. Top of page
    2. Editors’ View
    3. Pharmacodynamics
    4. Pharmacogenetics
    5. Pharmacokinetics
    6. Drug Metabolism
    7. Drug Distribution
    8. Therapeutics
    9. Clinical Trials
    10. Short Reports
    11. Book Review
    12. Letters to the Editor
    1. You have free access to this content
      Combined use of NSAIDs and SSRIs increases the risk for gastrointestinal adverse effects (page 119)

      Jeroen C. F. De Jong, Jacobus R. B. J. Brouwers and Lolkje T. W. De Jong-van den Berg

      Version of Record online: 16 DEC 2004 | DOI: 10.1111/j.1365-2125.2005.2212_2.x

    2. You have free access to this content
    3. You have free access to this content
      Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone (pages 120–122)

      Michi Wakaumi, Shuichi Tsuruoka, Koichi Sakamoto, Tsuyoshi Shiga and Akio Fujimura

      Version of Record online: 27 OCT 2004 | DOI: 10.1111/j.1365-2125.2004.02219.x

    4. You have free access to this content

SEARCH

SEARCH BY CITATION